<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transplantologiya</journal-id><journal-title-group><journal-title xml:lang="ru">Трансплантология</journal-title><trans-title-group xml:lang="en"><trans-title>Transplantologiya. The Russian Journal of Transplantation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-0506</issn><issn pub-type="epub">2542-0909</issn><publisher><publisher-name>IPO Association of Transplantologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23873/2074-0506-2023-15-4-499-506</article-id><article-id custom-type="elpub" pub-id-type="custom">transplantologiya-827</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Эффективность инсулинотерапии при тяжелом отравлении блокаторами кальциевых каналов</article-title><trans-title-group xml:lang="en"><trans-title>Efficacy of insulin therapy in severe poisoning with calcium channel blockers</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4736-1068</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Симонова</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Simonova</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анастасия Юрьевна Симонова - канд. мед. наук, ведущий научный сотрудник отделения острых отравле ний и соматопсихиатрических расстройств ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»; ассистент кафедры клинической токсикологии ФГБОУ ДПО РМАНПО МЗ РФ; старший научный сотрудник ФГБУ ФНКЦ ФХМ им. Ю.М. Лопухина ФМБА России.</p><p>129090, Москва, Большая Сухаревская пл., д. 3; 125993, Москва, Баррикадная ул., д. 2/1, стр. 1; 119435, Москва, Малая Пироговская ул., д. 1А</p></bio><bio xml:lang="en"><p>Anastasia Yu. Simonova -            Cand. Sci. (Med.), Leading Researcher, Department of Acute Poisonings and Somatopsychiatric Disorders, N.V. Sklifosovsky Research Institute for Emergency Medicine; Assistant of the Department of Clinical Toxicology, RMACPE; Senior Researcher, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency.</p><p>3 Bolshaya Sukharevskaya Sq., Moscow 129090; 2/1 Bldg.1 Barrikadnaya St., Moscow 125993; 1А Malaya Pirogovskaya St., Moscow 119435</p></bio><email xlink:type="simple">SimonovaAU@sklif.mos.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6137-8961</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильяшенко</surname><given-names>К. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilyashenko</surname><given-names>K. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Капиталина Константиновна Ильяшенко - проф., д-р мед. наук, научный консультант отделения острых отравлений и соматопсихиатрических расстройств ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»; ведущий научный сотрудник ФГБУ ФНКЦ ФХМ им. Ю.М. Лопухина ФМБА России.</p><p>129090, Москва, Большая Сухаревская пл., д. 3; 119435, Москва, Малая Пироговская ул., д. 1А</p></bio><bio xml:lang="en"><p>Kapitalina K. Ilyashenko - Prof., Dr. Sci. (Med.), Scientific Consultant, Department of Acute Poisonings and Somatopsychiatric Disorders, N.V. Sklifosovsky RIEM; Leading Researcher, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency.</p><p>3 Bolshaya Sukharevskaya Sq., Moscow 129090; 1А Malaya Pirogovskaya St., Moscow 119435</p></bio><email xlink:type="simple">IlyashenkoKK@sklif.mos.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0117-8663</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поцхверия</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Potskhveriya</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михаил Михайлович Поцхверия - д-р мед. наук, заведующий научным отделением острых отравлений и соматопсихиатрических расстройств ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»; доцент кафедры клинической токсикологии ФГБОУ ДПО РМАНПО МЗ РФ.</p><p>129090, Москва, Большая Сухаревская пл., д. 3; 125993, Москва, Баррикадная ул., д. 2/1, стр. 1</p></bio><bio xml:lang="en"><p>Michael M. Potskhveriya             Dr. Sci. (Med.), Head of Scientific Department of Acute Poisonings and Somatopsychiatric Disorders, N.V. Sklifosovsky RIEM; Associate Professor, Department of Clinical Toxicology, Russian Medical Academy of Continuous Professional Education.</p><p>3 Bolshaya Sukharevskaya Sq., Moscow 129090; 2/1 Bldg.1 Barrikadnaya St., Moscow 125993</p></bio><email xlink:type="simple">PotskhveriyaMM@sklif.mos.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3292-8789</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткешелашвили</surname><given-names>Т. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkeshelashvili</surname><given-names>T. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тенгиз Теймуразович Ткешелашвили - заведующий отделением реанимации и интенсивной терапии для экстренной детоксикации ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ».</p><p>129090, Москва, Большая Сухаревская пл., д. 3</p></bio><bio xml:lang="en"><p>Tengiz T. Tkeshelashvili - Head of Critical and Intensive Care Unit for Emergency Detoxification.</p><p>3 Bolshaya Sukharevskaya Sq., Moscow 129090</p></bio><email xlink:type="simple">TkeshelashviliTT@sklif.mos.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3292-8789</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петриков</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrikov</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергей Сергеевич Петриков - член-корр. РАН, д-р мед. наук, директор ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ».</p><p>129090, Москва, Большая Сухаревская пл., д. 3</p></bio><bio xml:lang="en"><p>Sergey S. Petrikov - Corresponding Member of the Russian Academy of Sciences, Dr. Sci. (Med.), Director of N.V. Sklifosovsky RIEM.</p><p>3 Bolshaya Sukharevskaya Sq., Moscow 129090</p></bio><email xlink:type="simple">PetrikovSS@sklif.mos.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»; ФГБОУ ДПО РМАНПО МЗ РФ; ФГБУ ФНКЦ ФХМ им. Ю.М. Лопухина ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.V. Sklifosovsky Research Institute for Emergency Medicine; Russian Medical Academy of Continuous Professional Education; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»; ФГБУ ФНКЦ ФХМ им. Ю.М. Лопухина ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.V. Sklifosovsky Research Institute for Emergency Medicine; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»; ФГБОУ ДПО РМАНПО МЗ РФ,</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.V. Sklifosovsky Research Institute for Emergency Medicine; Russian Medical Academy of Continuous Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.V. Sklifosovsky Research Institute for Emergency Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2023</year></pub-date><volume>15</volume><issue>4</issue><fpage>499</fpage><lpage>506</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Симонова А.Ю., Ильяшенко К.К., Поцхверия М.М., Ткешелашвили Т.Т., Петриков С.С., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Симонова А.Ю., Ильяшенко К.К., Поцхверия М.М., Ткешелашвили Т.Т., Петриков С.С.</copyright-holder><copyright-holder xml:lang="en">Simonova A.Y., Ilyashenko K.K., Potskhveriya M.M., Tkeshelashvili T.T., Petrikov S.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.jtransplantologiya.ru/jour/article/view/827">https://www.jtransplantologiya.ru/jour/article/view/827</self-uri><abstract><sec><title>Введение</title><p>Введение. В последние годы отмечено увеличение числа отравлений лекарственными средствами, влияющими преимущественно на сердечно-сосудистую систему, в том числе блокаторами кальциевых каналов. Согласно данным литературы, инсулинотерапия является эффективным и безопасным методом лечения пациентов с тяжелым отравлением блокаторами кальциевых каналов.</p></sec><sec><title>Цель</title><p>Цель. Демонстрация эффективности применения высоких доз инсулина при тяжелом отравлении блокаторами кальциевых каналов.</p></sec><sec><title>Результаты</title><p>Результаты. Пациент Т., 37 лет, принял с целью суицида 1000 таблеток нифедипина за 4–6 часов до поступления в стационар. В связи с развитием рефрактерного шока и неэффективностью базовой терапии (внутривенное введение 0,9% раствора хлористого натрия, хлорида кальция (насыщенной дозы), вазопрессорных/инотропных средств) принято решение о введение высоких доз инсулина. После болюсного внутривенного введения инсулина скорость его внутривенного введения составила 0,5 Ед/кг/час и постепенно была увеличена из-за отсутствия гемодинамического эффекта с шагом в 15–30 минут на 1–2 Ед/кг/час максимум до 8 Ед/кг/час при постоянном контроле уровня глюкозы и калия в крови. В результате были достигнуты целевые показатели гемодинамики. Затем постепенно снижали скорость инфузии инсулина и по достижении стабилизации гемодинамики его введение прекратили через 2 суток после начала. На 9-е сутки с момента госпитализации больной был переведен из отделения реанимации в отделение острых отравлений.</p></sec><sec><title>Вывод</title><p>Вывод. Представленное наблюдение показывает эффективность и целесообразность применения инсулинотерапии при развитии рефрактерного шока вследствие тяжелого отравления блокаторами кальциевых каналов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. In recent years, there has been an increased number of poisoning with drugs that mainly affect the cardiovascular system, including calcium channel blockers. According to foreign literature, insulin therapy is an effective and safe method of treating patients with severe poisoning with calcium channel blockers.</p></sec><sec><title>Aim</title><p>Aim. To demonstrate the efficacy of high-dose insulin in severe poisoning with calcium channel blockers.</p></sec><sec><title>Results</title><p>Results. Patient T., 37 years old, took 1000 tablets of nifedipine for suicide 4-6 hours before admission to the hospital. In connection with the development of refractory shock and the ineffectiveness of basic therapy (the intravenous administration of 0.9% sodium chloride solution, calcium chloride (saturated dose), vasopressor/inotropic agents), a decision was made to administer high doses of insulin. After a bolus intravenous injection of insulin, the rate of its intravenous administration was 0.5 U/kg/h and, due to the lack of hemodynamic effect, it was gradually increased in increments of 1–2 U/kg/h at every 15–30 minutes up to a maximum of 8 U/kg/h with constant monitoring of glucose and potassium levels in the blood. As a result, the target hemodynamic parameters were achieved. Then the insulin infusion rate was gradually reduced and, upon achieving hemodynamic stabilization, its administration was stopped 2 days after the start On the 9th day from the moment of hospital admission the patient was transferred from the Intensive Care Unit to the Acute Poisoning Department.</p></sec><sec><title>Conclusions</title><p>Conclusions. The presented case report shows the efficacy and expediency of using the insulin therapy in the developed refractory shock due to severe poisoning with calcium channel blockers.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>отравление блокаторами кальциевых каналов</kwd><kwd>острые химические отравления</kwd><kwd>блокаторы кальциевых каналов</kwd><kwd>инсулинотерапия</kwd><kwd>кардиогенный шок</kwd></kwd-group><kwd-group xml:lang="en"><kwd>poisoning with calcium channel blockers</kwd><kwd>acute chemical poisoning</kwd><kwd>calcium channel blockers</kwd><kwd>insulin therapy</kwd><kwd>cardiogenic shock</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проводилось без спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study was performed without external funding</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stephen VS, Pluymers NA, Gauton SJ. Emergency management of calcium channel blocker overdose. S Afr Med J. 2019;109(9):635–638. PMID: 31635586 https://doi.org/10.7196/SAMJ.2019.v109i9.13704</mixed-citation><mixed-citation xml:lang="en">Stephen VS, Pluymers NA, Gauton SJ. Emergency management of calcium channel blocker overdose. S Afr Med J. 2019;109(9):635–638. PMID: 31635586 https://doi.org/10.7196/SAMJ.2019.v109i9.13704</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">DeRoos F. Calcium channel blockers. In: Hoffman R. (ed.) Goldfrank’s Toxicologic Emergencies. 10th ed. New York: McGraw-Hill; 2015. p. 884–892.</mixed-citation><mixed-citation xml:lang="en">DeRoos F. Calcium channel blockers. In: Hoffman R. (ed.) Goldfrank’s Toxicologic Emergencies. 10th ed. New York: McGraw-Hill; 2015. p. 884–892.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Симонова А.Ю., Рожков П.Г., Белова М.В., Ильяшенко К.К., Поцхверия М.М., Остапенко Ю.Н. и др. Анализ токсикологической ситуации в Москве в первые три месяца пандемии COVID-19. Токсикологический вестник. 2021;29(5):49–57. https://doi.org/10.36946/0869-79222021-29-5-49-57</mixed-citation><mixed-citation xml:lang="en">Simonova AYu, Rozhkov PG, Belova MV, Ilyashenko KK, Potskhveriya MM, Ostapenko YuN, et al. Analysis of the toxicological situation in Moscow in the first three months of the COVID-19 pandemic. Toxicological Review. 2021;29(5):49–57. (In Russ.). https://doi.org/10.36946/0869-79222021-29-5-49-57</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ильяшенко К.К., Симонова А.Ю., Белова М.В. Структурный анализ острых экзотоксикозов в пожилом и старческом возрасте. Токсикологический вестник. 2017;1(142):10–14. https://doi.org/10.36946/08697922-2017-1-10-14</mixed-citation><mixed-citation xml:lang="en">Ilyashenko KK, Simonova AYu, Belova MV. A structural analysis of acute exotoxicoses in people of elderly and senile age. Toxicological Review. 2017;(1):10–14. (In Russ.). https://doi.org/10.36946/08697922-2017-1-10-14</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кукес В.Г., Стародубцев А.К. (ред.) Клиническая фармакология и фармакотерапия. Москва: ГЭОТАР-Медиа; 2006.</mixed-citation><mixed-citation xml:lang="en">Kukes VG, Starodubtsev AK. (eds.) Klinicheskaya farmakologiya i farmakoterapiya. Moscow: GEOTAR-Media Publ.; 2006. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Шилов А.М. Блокаторы кальциевых каналов III поколения при лечении артериальной гипертонии. Системные гипертензии. 2013;10(3):38–43.</mixed-citation><mixed-citation xml:lang="en">Shilov AM. Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii. Systemic Hypertension. 2013;10(3):38–43. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Хоффман Р., Нельсон Л., Хауланд М.-Э., Льюин Н., Фломенбаум Н., Голдфранк Л. Экстренная медицинская помощь при отравлениях: пер. с англ. Москва: Практика; 2010.</mixed-citation><mixed-citation xml:lang="en">Hoffman RS, Nelson LS, Howland MA, Lewis NA, Flomenbaum NE, Goldfrank LR. (eds.) Goldfrank’s manual of toxicologic emergencies. New York: McGrawHill Medical; 2007. (Russ. ed.: Khoffman R, Nelson L, Khauland M-E, Lyuin N, Flomenbaum N., Goldfrank L. Ekstrennaya meditsinskaya pomoshch’ pri otravleniyakh. Moscow: Praktika Publ.; 2010.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mowry JB, Spyker DA, Cantile na LR Jr, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014;52(10):1032–1283. PMID: 25559822 https://doi.org/10.3109/15563650.2014.987397</mixed-citation><mixed-citation xml:lang="en">Mowry JB, Spyker DA, Cantile na LR Jr, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014;52(10):1032–1283. PMID: 25559822 https://doi.org/10.3109/15563650.2014.987397</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36(1):1817–1824. PMID: 29452919 https://doi.org/10.1016/j.ajem.2018.02.004</mixed-citation><mixed-citation xml:lang="en">Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36(1):1817–1824. PMID: 29452919 https://doi.org/10.1016/j.ajem.2018.02.004</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Krenz JR, Kaakeh Y. An Overview of hyperinsulinemic-euglycemic therapy in calcium channel blocker and β-blocker overdose. Pharmacotherapy. 2018;38(11):1130–1142. PMID: 30141827 https://doi.org/10.1002/phar.2177</mixed-citation><mixed-citation xml:lang="en">Krenz JR, Kaakeh Y. An Overview of hyperinsulinemic-euglycemic therapy in calcium channel blocker and β-blocker overdose. Pharmacotherapy. 2018;38(11):1130–1142. PMID: 30141827 https://doi.org/10.1002/phar.2177</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Page CB, Ryan NM, Isbister GK. The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity. Clin Toxicol (Phila). 2018;56(6):389–396. PMID: 29069937 https://doi.org/10.1080/15563650.2017.1391391</mixed-citation><mixed-citation xml:lang="en">Page CB, Ryan NM, Isbister GK. The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity. Clin Toxicol (Phila). 2018;56(6):389–396. PMID: 29069937 https://doi.org/10.1080/15563650.2017.1391391</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Walter E, McKinlay J, Corbett J, Kirk-Bayley J. Review of management in cardiotoxic overdose and efficacy of delayed intralipid use. J Intensive Care Soc. 2018;19(1):50–55. PMID: 29456602 https://doi.org/10.1177/1751143717705802</mixed-citation><mixed-citation xml:lang="en">Walter E, McKinlay J, Corbett J, Kirk-Bayley J. Review of management in cardiotoxic overdose and efficacy of delayed intralipid use. J Intensive Care Soc. 2018;19(1):50–55. PMID: 29456602 https://doi.org/10.1177/1751143717705802</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar K, Biyyam M, Bajantri B, Nayudu S. Critical management of severe hypotension caused by amlodipine toxicity managed with hyperinsulinemia/ euglycemia therapy supplemented with calcium gluconate, intravenous glucagon and other vasopressor support: review of literature. Cardiol Res. 2018;9(1):46–49. PMID: 29479386 https://doi.org/10.14740/cr646w</mixed-citation><mixed-citation xml:lang="en">Kumar K, Biyyam M, Bajantri B, Nayudu S. Critical management of severe hypotension caused by amlodipine toxicity managed with hyperinsulinemia/ euglycemia therapy supplemented with calcium gluconate, intravenous glucagon and other vasopressor support: review of literature. Cardiol Res. 2018;9(1):46–49. PMID: 29479386 https://doi.org/10.14740/cr646w</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071–2075. PMID: 17855820 https://doi.org/10.1097/01.ccm.0000278916.04569.23</mixed-citation><mixed-citation xml:lang="en">Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071–2075. PMID: 17855820 https://doi.org/10.1097/01.ccm.0000278916.04569.23</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mégarbane B. High-dose insulin should be used before vasopressors/inotropes in calcium-channel blocker toxicity. Br J Clin Pharmacol. 2023;89(4):1269–1274. PMID: 36604796 https://doi.org/10.1111/bcp.15641</mixed-citation><mixed-citation xml:lang="en">Mégarbane B. High-dose insulin should be used before vasopressors/inotropes in calcium-channel blocker toxicity. Br J Clin Pharmacol. 2023;89(4):1269– 1274. PMID: 36604796 https://doi.org/10.1111/bcp.15641</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Skoog C, Engebretsen K. Are vasopressors useful in toxin-induced cardiogenic shock? Clin Toxicol (Phila). 2017;55(4):285–304. PMID: 28152638 https://doi.org/10.1080/15563650.2017.1284329</mixed-citation><mixed-citation xml:lang="en">Skoog C, Engebretsen K. Are vasopressors useful in toxin-induced cardiogenic shock? Clin Toxicol (Phila). 2017;55(4):285–304. PMID: 28152638 https://doi.org/10.1080/15563650.2017. 1284329</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Baselt RC. Disposition of toxic drugs and chemicals in man. 9th ed. Seal Beach, CA, USA: Biomed Publications; 2011.</mixed-citation><mixed-citation xml:lang="en">Baselt RC. Disposition of toxic drugs and chemicals in man. 9th ed. Seal Beach, CA, USA: Biomed Publications; 2011.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Woodward C, Pourmand A, MazerAmirshai M. High-dose insulin therapy, an evidence-based approach to betablocker/calcium channel blocker toxicity. Daru. 2014;22(1):36. PMID: 24713415 https://doi.org/10.1186/2008-2231-22-36</mixed-citation><mixed-citation xml:lang="en">Woodward C, Pourmand A, MazerAmirshai M. High-dose insulin therapy, an evidence-based approach to betablocker/calcium channel blocker toxicity. Daru. 2014;22(1):36. PMID: 24713415 https://doi.org/10.1186/2008-2231-22-36</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
